184 related articles for article (PubMed ID: 36059700)
41. Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type.
Huang Y; de Reyniès A; de Leval L; Ghazi B; Martin-Garcia N; Travert M; Bosq J; Brière J; Petit B; Thomas E; Coppo P; Marafioti T; Emile JF; Delfau-Larue MH; Schmitt C; Gaulard P
Blood; 2010 Feb; 115(6):1226-37. PubMed ID: 19965620
[TBL] [Abstract][Full Text] [Related]
42. Suppression of latent transforming growth factor-β (TGF-β)-binding protein 1 (LTBP1) inhibits natural killer/ T cell lymphoma progression by inactivating the TGF-β/Smad and p38
Lin R; Li X; Wu S; Qian S; Hou H; Dong M; Zhang X; Zhang M
Exp Cell Res; 2021 Oct; 407(1):112790. PubMed ID: 34418460
[TBL] [Abstract][Full Text] [Related]
43. Prognostic implications of CD30 expression in extranodal natural killer/T-cell lymphoma according to treatment modalities.
Kim WY; Nam SJ; Kim S; Kim TM; Heo DS; Kim CW; Jeon YK
Leuk Lymphoma; 2015 Jun; 56(6):1778-86. PubMed ID: 25288491
[TBL] [Abstract][Full Text] [Related]
44. MiRNA-155 regulates lymphangiogenesis in natural killer/T-cell lymphoma by targeting BRG1.
Chang Y; Cui M; Fu X; Zhang L; Li X; Li L; Wu J; Sun Z; Zhang X; Li Z; Nan F; Yan J; Zhang M
Cancer Biol Ther; 2019; 20(1):31-41. PubMed ID: 30299211
[TBL] [Abstract][Full Text] [Related]
45. Exome sequencing identifies somatic mutations of DDX3X in natural killer/T-cell lymphoma.
Jiang L; Gu ZH; Yan ZX; Zhao X; Xie YY; Zhang ZG; Pan CM; Hu Y; Cai CP; Dong Y; Huang JY; Wang L; Shen Y; Meng G; Zhou JF; Hu JD; Wang JF; Liu YH; Yang LH; Zhang F; Wang JM; Wang Z; Peng ZG; Chen FY; Sun ZM; Ding H; Shi JM; Hou J; Yan JS; Shi JY; Xu L; Li Y; Lu J; Zheng Z; Xue W; Zhao WL; Chen Z; Chen SJ
Nat Genet; 2015 Sep; 47(9):1061-6. PubMed ID: 26192917
[TBL] [Abstract][Full Text] [Related]
46. [Immune Microenvironment Comparation Study between EGFR Mutant and EGFR Wild Type Lung Adenocarcinoma Patients Based on TCGA Database].
Zhu G; Li Y; Shi R; Xu S; Zhang Z; Cao P; Chen C; Liu H; Chen J
Zhongguo Fei Ai Za Zhi; 2021 Apr; 24(4):236-244. PubMed ID: 33910272
[TBL] [Abstract][Full Text] [Related]
47. Frequent Mutations in Natural Killer/T Cell Lymphoma.
Zhang Y; Li C; Xue W; Zhang M; Li Z
Cell Physiol Biochem; 2018; 49(1):1-16. PubMed ID: 30134235
[TBL] [Abstract][Full Text] [Related]
48. Updating targets for natural killer/T-cell lymphoma immunotherapy.
Xue W; Zhang M
Cancer Biol Med; 2021 Feb; 18(1):52-62. PubMed ID: 33628584
[TBL] [Abstract][Full Text] [Related]
49. m6A methyltransferase Wilms' tumor 1-associated protein facilitates cell proliferation and cisplatin resistance in NK/T cell lymphoma by regulating dual-specificity phosphatases 6 expression via m6A RNA methylation.
Ma H; Shen L; Yang H; Gong H; Du X; Li J
IUBMB Life; 2021 Jan; 73(1):108-117. PubMed ID: 33205540
[TBL] [Abstract][Full Text] [Related]
50. A retrospective study on the clinicopathological and molecular features of 22 cases of natural killer/T-cell lymphoma in children and adolescents.
Wang GN; Zhao WG; Zhang XD; Jian XY; Zhang CL; Zhang MZ; Li WC
Sci Rep; 2022 May; 12(1):7118. PubMed ID: 35504960
[TBL] [Abstract][Full Text] [Related]
51. Nasal NK/T-Cell Lymphoma. A Comparative Analysis of a Mexican Population with the Other Populations of Latin-America.
Avilés A
Mediterr J Hematol Infect Dis; 2015; 7(1):e2015052. PubMed ID: 26401241
[TBL] [Abstract][Full Text] [Related]
52. Sonidegib, a Smoothened Inhibitor, Promotes Apoptosis and Suppresses Proliferation of Natural Killer/T-Cell Lymphoma.
Liu S; Li C; Xin P; Zheng Y; Peng Q; Xu Y; Luo Y; Wu Y; Zhu X
Med Sci Monit; 2019 Nov; 25():8579-8586. PubMed ID: 31724562
[TBL] [Abstract][Full Text] [Related]
53. Extranodal NK/T-cell lymphoma: toward the identification of clinical molecular targets.
Schmitt C; Sako N; Bagot M; Huang Y; Gaulard P; Bensussan A
J Biomed Biotechnol; 2011; 2011():790871. PubMed ID: 21541194
[TBL] [Abstract][Full Text] [Related]
54. Treatment, Survival, and Prognosis of Advanced-Stage Natural Killer/T-Cell Lymphoma: An Analysis From the China Lymphoma Collaborative Group.
Liu W; Yang Y; Qi S; Wang Y; He X; Zhang L; Qu B; Qian L; Hou X; Qiao X; Wang H; Li G; Zhang Y; Zhu Y; Cao J; Wu J; Wu T; Zhu S; Shi M; Xu L; Su H; Lin N; Zhu J; Li Y; Song Y
Front Oncol; 2020; 10():583050. PubMed ID: 33718104
[TBL] [Abstract][Full Text] [Related]
55. Towards Next Generation Biomarkers in Natural Killer/T-Cell Lymphoma.
Chan JY; Lim JQ; Ong CK
Life (Basel); 2021 Aug; 11(8):. PubMed ID: 34440582
[TBL] [Abstract][Full Text] [Related]
56. PEG-L-CHOP treatment is safe and effective in adult extranodal NK/T-cell lymphoma with a low rate of clinical hypersensitivity.
Zheng W; Gao Y; Ke X; Zhang W; Su L; Ren H; Lin N; Xie Y; Tu M; Liu W; Ping L; Ying Z; Zhang C; Deng L; Wang X; Song Y; Zhu J
BMC Cancer; 2018 Sep; 18(1):910. PubMed ID: 30241515
[TBL] [Abstract][Full Text] [Related]
57. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes.
Vose J; Armitage J; Weisenburger D;
J Clin Oncol; 2008 Sep; 26(25):4124-30. PubMed ID: 18626005
[TBL] [Abstract][Full Text] [Related]
58. IL-13 and IL-13Rα1 are overexpressed in extranodal natural killer/T cell lymphoma and mediate tumor cell proliferation.
Zhang Y; Li C; Zhang M; Li Z
Biochem Biophys Res Commun; 2018 Sep; 503(4):2715-2720. PubMed ID: 30107911
[TBL] [Abstract][Full Text] [Related]
59. Nasal Type Extranodal Natural Killer/T (NK/T) Cell Lymphoma Presenting as Periorbital Cellulitis: A Case Report.
Al Shawabkeh MA; Al Sulaiti M; Al Sa'ey H; Ganesan S
Am J Case Rep; 2016 Dec; 17():934-938. PubMed ID: 27932776
[TBL] [Abstract][Full Text] [Related]
60. Icaritin inhibits PLK1 to activate DNA damage response in NK/T cell lymphoma and increases sensitivity to GELOX regime.
Zhang C; Xu H; Sui X; Chen L; Chen B; Lv H; Wang S; Wang X
Mol Ther Oncolytics; 2022 Jun; 25():288-304. PubMed ID: 35663228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]